Lorshil SP Tablet
By Lorshil SP
Rx
10 Tablet in a Strip

Composition
Lornoxicam(4mg) + Paracetamol(325mg) + Serratiopeptidase(15mg)

Manufacturer - Prashil Life Sciences Pvt Ltd
28, Vishwas City-5 Gota, Ahmedabad-382481 Gujarat, India

Expires on or after
October, 2025

liver
Caution should be taken when using Lorshil SP Tablet in patients with liver disease. It may be necessary to adjust the dose of the tablet, so it's important to consult your doctor before starting the medication. However, it is advised not to use Lorshil SP Tablet in patients with severe liver disease or active liver disease.

kidney
Limited data suggests Lorshil SP Tablet is likely safe for patients with kidney disease. Consult your doctor for guidance; dose adjustment may not be required.

alcohol
It is unsafe to drink alcohol while taking Lorshil SP Tablet. Avoid consuming alcohol with this medication.

driving
Lorshil SP Tablet may cause drowsiness, affect vision, or reduce alertness. Avoid driving if experiencing these effects.

pregnancy
Lorshil SP Tablet is not recommended during pregnancy due to potential risks to the baby. In life-threatening situations, a doctor may consider it if benefits outweigh risks. Consult your doctor regarding its use.

breastfeeding
It is better to consult your doctor before using Lorshil SP Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹45
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025